Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee

NCT07226258 is registered in ClinicalTrials.gov with Saol Therapeutics Inc as lead sponsor.

NCT NCT07226258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee
Lead sponsor
Saol Therapeutics Inc
Phase
Phase 3
Overall status
Recruiting
Start date
November 7, 2025
Completion date
February 28, 2027
Enrollment
150 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis knee pain